Neoadjuvant Anti-Angiogenesis Therapy for Prostate Cancer

Abstract

This proposed clincial trial targets men at risk for recurrence after prostatectomy by treating systemic micrometastatic disease in addition to local. Thus far, anti-angiogenesis therapy is safe in men undergoing radical prostatectomy and postulated changes in angiogenic factors as well as grade and stage have been observed.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Aug 01, 2004
Accession Number
ADA437213

Entities

People

  • Mitchel H. Sokoloff

Organizations

  • University of Chicago

Tags

DTIC Thesaurus Topics

  • Ablation
  • Abstracts
  • African Americans
  • Androgens
  • Angiogenesis
  • Clinical Trials
  • Diseases And Disorders
  • Health Services
  • Medical Personnel
  • Neoplasms
  • Oncology
  • Prostate
  • Prostate Cancer
  • Standards
  • Surgery
  • Survival
  • Therapy

Fields of Study

  • Medicine
  • Physics

Readers

  • Oncology (Cancer Research).
  • Women's Health and Cancer Risk Research: African American Women and Pregnancy Outcomes.